title: Response to comment on Balkau et al. Factors associated with weight gain in people with type 2 diabetes starting on insulin. Diabetes Care 2014;37:2108-2113.
authors.affiliation: INSERM Centre for Research in Epidemiology and Population Health, U1018, Villejuif, France University Paris-Sud, URMS 1018, Villejuif, France beverley.balkau@inserm.fr.
authors.forename: Beverley
authors.initials: B
authors.lastname: Balkau
authors.affiliation: Newcastle University, Newcastle upon Tyne, U.K.
authors.forename: Philip D
authors.initials: PD
authors.lastname: Home
authors.affiliation: Sanofi, Paris, France.
authors.forename: Maya
authors.initials: M
authors.lastname: Vincent
authors.affiliation: INSERM U695, University of Paris 7, Paris, France.
authors.forename: Michel
authors.initials: M
authors.lastname: Marre
authors.affiliation: University College London, London, U.K.
authors.forename: Nick
authors.initials: N
authors.lastname: Freemantle
mesh_terms: D003924:Diabetes Mellitus, Type 2 / Q000517:prevention & control*; D003925:Diabetic Angiopathies / Q000517:prevention & control*; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D007328:Insulin / Q000627:therapeutic use*; D008297:Male; D015430:Weight Gain / Q000187:drug effects*
chemical_list: D007004:Hypoglycemic Agents; D007328:Insulin